Abstract
This laboratory has generated a series of seven cadmium (Cd+2)- and six arsenite (As+3)-transformed urothelial cancer cell lines by exposure of parental UROtsa cells to each agent under similar conditions of exposure. In this study, the seven Cd+2-transformed cell lines were characterized for the expression of keratin 6, 16, and 17 while the six As+3 cell lines were assessed for the expression of keratin 7 and 19. The results showed that the series of Cd+2-transformed cell lines and their respective transplants all had expression of keratin 6, 16, and 17 mRNA and protein. The expression of keratin 6, 16, and 17 was also correlated with areas of the urothelial tumor cells that had undergone squamous differentiation. The results also showed that four of the six As+3-transformed cell lines had expression of keratin 7 and 19 mRNA and protein and produced subcutaneous tumors with intense focal staining for keratin 7 and 19. The other two As+3-transformed cell lines had very low expression of keratin 7 mRNA and protein and produced subcutaneous tumors having no immunoreactivity for keratin 7; although keratin 19 expression was still present. The peritoneal tumors produced by one of these two cell lines regained expression of keratin 7 protein. The present results, coupled with previous studies, indicate that malignant transformation of UROtsa cells by Cd+2 or As+3 produce similar patterns of keratin 6, 7, 16, 17, and 19 in the resulting series of cell lines and their respective tumors.
Similar content being viewed by others
Abbreviations
- As+3 :
-
Arsenic
- Cd+2 :
-
Cadmium
- DAPI:
-
4′,6-diamidino-2-phenylindole
- DMEM:
-
Dulbecco’s modified Eagle’s medium
References
Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrsjot L, Orntoft TF. Gene expression profiling of noninvasive primary urothelial tumors using microarrays. Br J Cancer. 2005;14;93(10):1182–90.
Akdas A, Turkeri L. The impact of squamous metaplasia in transitional cell carcinoma of the bladder. Int J Urol Nephrol. 1990;23:333–6.
Alonso A, Ikinger U, Kartenbeck J. Staining patterns of keratins in the human urinary tract. Histol Histopathol. 2009;24:1425–37.
Bischoff CJ, Clark PE. Bladder cancer. Curr Opin Oncol. 2009;21:272–7.
Cantor KP, Lubin JH. Arsenic, internal cancers, and issues in inference from studies at low-level exposures in human populations. Toxicol Appl Pharmacol. 2007;222:252–7.
Cao L, Zhou XD, Sens MA, Garrett SH, Zheng Y, Dunlevy JR, Sens DA, Somji S. Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+)3-induced bladder cancer. J Appl Toxicol. 2010;30(5):416-30.
Chiou HY, Hsueh Y, Liaw KF, Hong SF, Chiang MH, Pu YS, et al. Incidence of internal cancers and ingested inorganic arsenic: a 7-year follow-up study in Taiwan. Cancer Res. 1995;55:1296–300.
Chu P, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–39.
Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962–72.
Frazier HA, Robertson JE, Dodge RK, Paulson DF. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1993;71:3993–4001.
Jiang J, Ulbright TM, Younger C, Sanchez K, Bostwick D, Kock MO, et al. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch Pathol Lab Med. 2001;125:921–3.
Kellen E, Zeegers M, Hond ED, Buntinx F. Blood cadmium may be associated with bladder carcinogenesis; the Belgian case control study on bladder cancer. Cancer Detect Prev. 2007;31:77–82.
Logothetis CJ, Dexeus FH, Chong C, Sella A, Ayala AG, Ro JY, et al. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the MD Anderson experience. J Urol. 1989;141:33–7.
Luster MI, Simeonova PP. Arsenic and urinary bladder cell proliferation. Toxicol Appl Pharmacol. 2004;198:419–23.
Martin JE, Jenkins BJ, Zuk RJ, Blandy JP, Baithun SI. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol. 1989;42:250–3.
Moll R, Divo M, Langhein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705–33.
Rossi MR, Masters JRW, Park S, Todd JH, Garrett SH, Sens MA, et al. The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect. 2001;109:801–8.
Satarug S, Garrett SH, Sens MA, Sens DA. Cadmium, environmental exposure and health outcomes. Environ Health Perspect. 2010;118:182–90.
Satarug S, Moore MR. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect. 2004;112:1099–103.
Sens DA, Park S, Gurel V, Sens MA, Garrett SH, Somji S. Inorganic cadmium-and arsenit-induced malignant transformation of human bladder urothelial cells. Toxicol Sci. 2004;79(1):56–63.
Siemiatycki J, Dewar R, Nadon L, Gerin M. Occupational risk factors for bladder cancer: Results from a case control study in Montreal, Quebec, Canada. Am J Epidemiol. 1994;140:1061–80.
Smith AH, Goycolea M, Haque R, Biggs ML. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 1998;147:660–9.
Somji S, Zhou XD, Mehus A, Sens MA, Garrett SH, Lutz KL, et al. Variation of keratin 7 expression and other phenotypic characteristics of independent isolates of cadmium transformed human urothelial cells (UROtsa). Chem Res Toxicol. 2010;23:348–56.
Steinmaus C, Moore L, Hopenhayn-Rich C, Biggs ML, Smith AH. Arsenic in drinking water and bladder cancer. Cancer Invest. 2000;18:174–82.
Tsuda T, Babazono A, Yamamoto E, Kurumatini N, Mino Y, Ogawa T, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol. 1995;141:198–209.
Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem. 2000;79:241–4.
Wang NP, Zee S, Zarbo RJ. Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem. 1995;51:219–23.
Acknowledgment
The research described was supported by grant number R01 ES015100 from the National Institute of Environmental Health Sciences, NIH. The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Somji, S., Cao, L., Mehus, A. et al. Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As+3- and Cd+2-induced bladder cancer. Cell Biol Toxicol 27, 381–396 (2011). https://doi.org/10.1007/s10565-010-9169-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-010-9169-z